Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Cellular and Molecular Life Sciences : CMLS|April 30, 2026
CircRPPH1 promotes hepatocellular carcinoma progression through inhibiting PPARα transcription and accelerating its ubiquitination and degradationWenxiu Ru, Yu Lu, Lunbiao Gan, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 3, 2002
A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populationsYing Liu, Ciren Zhuoma, Guangliang Shan, et al.
Medicine|February 23, 2023
Percutaneous nephroscopy combined with the laser used for right kidney bullet extraction: A case reportBaolong Wang, Lijun Yang, Jianlin Yuan, et al.
Biochemical and Biophysical Research Communications|December 19, 2020
A novel human anti-TIGIT monoclonal antibody with excellent function in eliciting NK cell-mediated antitumor immunityDong Han, Yinfeng Xu, Xinping Zhao, et al.
Frontiers in Pharmacology|February 6, 2023
Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progressionJiayu Zhang, Shiqi Lu, Tong Lu, et al.
Prostate Cancer and Prostatic Diseases|December 30, 2023
Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decisionShikuan Guo, Jingliang Zhang, Yingmei Wang, et al.
Theranostics|August 10, 2021
Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68Ga-PSMA PET/CT: a real-world studyJianhua Jiao, Fei Kang, Jingliang Zhang, et al.
Annals of Translational Medicine|January 24, 2022
CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinomaShaojie Liu, Chao Xu, Keying Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNAQiang Zhang, Zheng Cai, Lorenzo Gerratana, et al.
Frontiers in Oncology|December 6, 2021
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the BladderYu Li, Keying Zhang, Fa Yang, et al.
Pageof 15